See every side of every news story
Published loading...Updated

Zacks Research Has Pessimistic Outlook of TEVA Q4 Earnings

Summary by ETF Daily News
Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) – Research analysts at Zacks Research reduced their Q4 2025 earnings estimates for Teva Pharmaceutical Industries in a research note issued to investors on Wednesday, March 5th. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of $0.66 for the quarter, […]
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

ETF Daily News broke the news in on Saturday, March 8, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.